Search results for "obstetric"

showing 10 items of 2144 documents

Serial examination of 20,248 newborn fetuses and infants: Correlations between drug exposure and major malformations

1996

Maternal medication during the first trimester of pregnancy has been discussed as a risk factor for development of birth defects. The correlation between maternal drug use and major malformations was investigated in a population-based case-control study in Mainz. Over a period of 5 years (1990–1994), 20,248 livebirths, stillbirths, and abortions underwent physical and sonographic examination, and anamnestic data were collected. A total of 1,472 births with congenital anomalies (cases) and 9,682 births without major and minor malformations (controls) were analyzed. We distinguished between 30 different drug categories, which were divided into medication taken continuously (before and during …

education.field_of_studyPregnancymedicine.medical_specialtyGenitourinary systembusiness.industryObstetricsPopulationOdds ratiomedicine.diseaseConfidence intervalTeratologyGestationMedicineRisk factoreducationbusinessGenetics (clinical)American Journal of Medical Genetics
researchProduct

Multiple pregnancies and environmental exposure: An impact of air pollution on fetal growth?

2018

Introduction Multiple pregnancies display all the complications of singletons, but in highest frequencies, especially for fetal growth abnormalities. In singletons, air pollution seems to be negatively associated with fetal growth. A similar relationship in multiple pregnancies can be expected. However, multiple pregnancies are systematically excluded from the studies of the impact of air pollution on pregnancy outcomes. This study aims to analyze in a population of multiple pregnancies the relationship between fetal growth restriction (FGR), small for gestational age (SGA) and environmental chronic exposure to air pollution in moderately polluted cities. Methods All the multiple pregnancie…

education.field_of_studymedicine.medical_specialtyPregnancyFetusEpidemiologybusiness.industryObstetricsBirth weightPopulationPublic Health Environmental and Occupational HealthOdds ratioEnvironmental exposuremedicine.diseaseConfidence intervalMedicineSmall for gestational ageeducationbusinessRevue d'Épidémiologie et de Santé Publique
researchProduct

Embarazo ectópico intersticial tratado con metotrexato y cirugía: caso clínico

2019

RESUMEN Antecedentes: El embarazo intersticial es muy inusual y representa <2,4% de todos las gestaciones ectópicas. Objetivo: Se presenta el caso de un embarazo ectópico intersticial tratado de forma médica y quirúrgica. Se realiza una revisión literaria sobre las opciones de manejo y tratamiento. Caso clínico: Paciente primigesta de 36 años con gestación ectópica cornual derecha tras 11 días de la transferencia de un embrión criopreservado. Se decide tratamiento con metotrexato (MTX) sin éxito y con progresión del embarazo, obligándonos por lo tanto a realizar una evacuación quirúrgica de la gestación, exponiendo a la paciente tanto a los efectos secundarios del tratamiento médico como a …

embarazo cornualEmbarazo intersticialmetotrexatoObstetrics and GynecologyRevista chilena de obstetricia y ginecología
researchProduct

Manejo del parto, puerperio y lactancia en mujeres positivas por SARS-CoV-2. Estudio multicéntrico en la Comunidad Valenciana

2021

Objetivo: Determinar las repercusiones maternas y perinatales de las gestantes con reacciónen cadena de la polimerasa positiva para SARS-CoV-2 durante el parto y el puerperio clínico.Método: Estudio observacional descriptivo, retrospectivo y multicéntrico realizado mediantela revisión de historias clínicas de las gestantes ingresadas por parto desde el 1 de marzo hastael 30 de junio de 2020.Resultados: Se analizaron 13 mujeres con reacción en cadena de la polimerasa positiva a SARS-CoV-2. La prevalencia de casos positivos fue del 0,48% sobre el total de partos atendidos en elperiodo de estudio. Ninguna de las madres desarrolló complicaciones derivadas de la infecciónpor COVID-19 ni necesitó…

embarazoEmbarazobreastfeedingSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Breastfeedinglactancia maternachildbirthLactancia MaternaArticleValencian communityParto03 medical and health sciences0302 clinical medicinePregnancyMedicineGeneral Nursing030219 obstetrics & reproductive medicinebusiness.industrySARS-CoV-2COVID-19General MedicineChildbirth030220 oncology & carcinogenesispartopregnancybusinessHumanities
researchProduct

Serum miRNAs in women affected by hyperandrogenic polycystic ovary syndrome: the potential role of miR-155 as a biomarker for monitoring the estropro…

2018

MicroRNAs can be used as very efficient circulating biomarkers. The role of microRNAs in polycystic ovary syndrome (PCOS) and the effects of antiandrogen therapy on microRNA expression is still not fully understood. A panel of serum microRNAs were retrotranscribed via looped reverse primer transcription specific for each miRNA and quantified via probe specific RT-PCR in 16 Caucasian hyperandrogenic PCOS women selected according to the Rotterdam criteria and in a subset of seven patients after four months of sequential reverse antiandrogenic therapy. All women recruited underwent an oral glucose tolerance test (OGTT) and a baseline total cholesterol, high density lipoproteins cholesterol, tr…

endocrine system diseasesEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismurologic and male genital diseasesSettore MED/13 - EndocrinologiamiR-155mir-15503 medical and health sciences0302 clinical medicineEndocrinologymicroRNAMedicineHumansAntiandrogen Therapy030219 obstetrics & reproductive medicineantiandrogenic therapy; biomarker; mir-155; Polycystic ovary syndrome; visceral adipose index; Endocrinology Diabetes and Metabolism; Endocrinology; Obstetrics and Gynecologybusiness.industryantiandrogenic therapyfungifood and beveragesObstetrics and GynecologyAndrogen Antagonistsvisceral adipose indexPolycystic ovaryCirculating biomarkersMicroRNAsCancer researchBiomarker (medicine)biomarkerFemalebusinesshormones hormone substitutes and hormone antagonistsBiomarkersPolycystic Ovary SyndromeGynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
researchProduct

Intra-individual variability in TSH levels of healthy women during the first half of pregnancy

2017

TSH is the parameter most widely accepted to assess thyroid function, especially in pregnant women. The aim of this current study was to analyze intra-individual changes in TSH during the first half of pregnancy in women with TSH levels higher than 2.5mIU/L in early pregnancy.An observational, prospective study was conducted on 243 healthy pregnant women in the first trimester of pregnancy. Thyroid function was assessed by testing TSH and free T4 levels. A subgroup of women with TSH levels2.5mIU/L underwent additional tests (TSH, free T4, peroxidase antibodies). Information on dietary iodine intake and/or iodine supplements was also recorded.Mean TSH level was 1.89mIU/L (range 0.024-6.48mIU…

endocrine system diseasesEndocrinology Diabetes and MetabolismThyrotropinPhysiologyEarly pregnancy factor0302 clinical medicineEndocrinologyPregnancyReference ValuesProspective Studies030212 general & internal medicineYoung adultProspective cohort studyNutrition and Dieteticsbiologymedicine.diagnostic_testObstetricsMiddle AgedIntra individualParityIodised saltFemaleThyroid functionhormones hormone substitutes and hormone antagonistsIodineAdultendocrine systemmedicine.medical_specialtyAdolescentchemistry.chemical_element030209 endocrinology & metabolismIodineThyroid function testsYoung Adult03 medical and health sciencesInternal medicineDiabetes mellitusmedicineHumansSodium Chloride DietaryAutoantibodiesPregnancybusiness.industrymedicine.diseaseDietPregnancy Trimester FirstThyroxineFirst trimesterEndocrinologyBiological Variation PopulationchemistryDietary Supplementsbiology.proteinPrimer (molecular biology)businessEndocrinología, Diabetes y Nutrición
researchProduct

Serum inhibin A, inhibin B, pro-alphaC, and activin A levels in women with idiopathic premature ovarian failure.

2003

Serum inhibin A, inhibin B, pro-alphaC, and activin A levels in 30 women with idiopathic premature ovarian failure (POF), 30 postmenopausal women, and 30 age-matched fertile women were determined. Women with POF showed low levels of inhibin A and inhibin B, but not of activin A, whereas the levels of pro-alphaC were significantly higher than in postmenopausal women. Thus, the circulating level of pro-alphaC could be a marker for assessing residual ovarian function in women with POF.

endocrine systemInhibin amedicine.medical_specialtyendocrine system diseasesPrimary Ovarian InsufficiencyAndrologyOvarian functionInternal medicineMedicineHumansInhibinsProtein Precursorsreproductive and urinary physiologyInhibin bPostmenopausal womenbusiness.industryObstetrics and Gynecologyfemale genital diseases and pregnancy complicationsActivin aPostmenopauseIdiopathic premature ovarian failureEndocrinologyReproductive MedicineFemalebusinesshormones hormone substitutes and hormone antagonistsFertility and sterility
researchProduct

Expression of tenascin in human cervical cancer--association of tenascin expression with clinicopathological parameters.

1999

Tenascin is an extracellular matrix glycoprotein, relevant for embryonal and fetal development, which is reexpressed in the stroma of benign and malignant tumors. Little is known about the molecular interaction of tenascin during neoplastic transformation and tumor progression in cervical cancer.We studied the expression of tenascin in normal tissue of the cervix uteri, cervical carcinoma in situ, and invasive cervical carcinoma in paraffin sections by immunohistochemistry using a monoclonal antibody. Tenascin immunoreactivity was compared with various prognostic parameters.In normal cervical tissue (n = 5) and in cervical carcinoma in situ (n = 10) only vessel walls showed a weak tenascin …

endocrine systemPathologymedicine.medical_specialtyanimal structuresStromal cellConnective tissueTenascinUterine Cervical NeoplasmsMalignant transformationmedicineHumansNeoplastic transformationCervixRetrospective Studiesbiologybusiness.industryObstetrics and GynecologyTenascinmusculoskeletal systemPrognosisImmunohistochemistrySurvival Ratemedicine.anatomical_structureOncologyTumor progressionembryonic structuresbiology.proteinDisease ProgressionImmunohistochemistryFemalebusinessCarcinoma in SituGynecologic oncology
researchProduct

Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome

2008

BACKGROUND: Ovarian hyperstimulation syndrome (OHSS) typically occurs when ovaries are primed with FSH/ LH and subsequently exposed to hCG. The ultimate pathophysiological step underlying this clinical picture is increased vascular permeability (VP). METHODS: A search of the literature was carried out using PubMed and the authors’ files. RESULTS: In rodents and humans, the expression of vascular endothelial growth factor (VEGF) and VEGF receptor 2 (VEGFR-2) mRNA increases during ovarian stimulation. With the administration of hCG, the expression of each rises to a maximum. Expression of VEGF/VEGFR-2 mRNAs correlates with enhanced VP, with both peaking 48 h following an injection of hCG. Imm…

endocrine systemmedicine.medical_specialtyCabergolineIndolesOvarian hyperstimulation syndromeVascular permeabilityBiologyChorionic GonadotropinDopamine agonistCapillary PermeabilityOvarian Hyperstimulation Syndromechemistry.chemical_compoundInternal medicineCabergolinemedicineAnimalsHumansPyrrolesErgolinesPhosphorylationCells CulturedClinical Trials as TopicEstradiolVascular Endothelial Growth FactorsObstetrics and GynecologyEstrogensKinase insert domain receptormedicine.diseaseRatsVascular endothelial growth factorActin CytoskeletonVascular endothelial growth factor Amedicine.anatomical_structureEndocrinologyReproductive MedicinechemistryDopamine AgonistsReproductive Control AgentsFemaleCorpus luteumSignal Transductionmedicine.drugHuman Reproduction Update
researchProduct

Concentrations of ovarian proteohormones as biological markers for the outcome of assisted reproductive technology

2002

Objective: To assess whether the ovarian proteohormones inhibin A and B, pro-alpha-C and activin A could act as direct biological markers of a poorer or better response to ovulation induction or clinical conception through assisted reproductive technology (ART). Methods: Seventy-seven women who underwent ART were included in the study and were divided into two groups: (i) 46 women with sonographically documented follicular maturation; and (ii) 36 women who demonstrated inadequate follicle development. Blood samples were analyzed for inhibin A, inhibin B, pro-alpha-C, activin A and estradiol (E2) at day 3 of stimulation with recombinant follicle-stimulating hormone (rFSH) after pituitary dow…

endocrine systemmedicine.medical_specialtyInhibin aAssisted reproductive technologyIn vitro fertilisationbusiness.industrymedicine.medical_treatmentObstetrics and GynecologyStimulationAndrologyFollicleEndocrinologyInternal medicinemedicineOvulation inductionbusinesshormones hormone substitutes and hormone antagonistsInhibin bHormoneJournal of Obstetrics and Gynaecology Research
researchProduct